Breast Cancer

The de-escalation and treatment personalization of patients with early breast cancer has advanced in recent years, with studies such as…

A five-part VJ Session with breast cancer experts Erika Hamilton, Matteo Lambertini and Sibylle Loibl, who discuss the key highlights…

Seattle Genetics have announced the U.S. Food and Drug Administration (FDA) have granted approval for tucatinib in combination with trastuzumab…

The early detection of cancer improves outcomes for patients – in terms of both reducing treatment burden and improving the…

The Enhanced Recovery After Surgery (ERAS) approach was initially pioneered for colorectal surgery by a group of surgeons in northern…

Breast cancer is the most common type of malignancy in women.1 Human epidermal growth factor receptor 2 (HER2) positive breast…

It has been known for almost a century that thoracic radiotherapy can cause damage to the heart.[2] However, the first…

Women over 50 who have been treated for ductal carcinoma in situ (DCIS) are more likely to be alive ten…